Bayer Kills 'Misrepresentative' Mark For 'Flanax' At TTAB

Law360, New York (April 21, 2014, 2:15 PM EDT) -- Bayer AG, which sells its Aleve brand as “Flanax” outside the United States, won a precedential ruling at the Trademark Trial and Appeal Board last week canceling a registration on the name that the board said was a “blatant” attempt to confuse Latin American consumers.

Bayer has long used the name outside the U.S., including in neighboring Mexico, for the naproxen-based painkillers it sells domestically as “Aleve”; a company called Belmora LLC registered the same name in 2004 and was using it to sell that drug domestically.

In granting Bayer's bid to cancel the registration on April 17, the board said...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related

Sections

Law Firms

Companies

Government Agencies